AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
January 7, 2020

CGH patient education spotlight: biosimilars

Help your IBD patients understand their treatment options.
Share on facebook
Share on twitter
Share on linkedin
Share on email

As the U.S. Food and Drug Administration approves new biosimilar drugs, more patients will have questions about the treatment for inflammatory bowel disease (IBD).

AGA wants to help patients better understand biosimilar drugs and who should take them. Share the AGA Patient Education Section in the January 2020 issue of Clinical Gastroenterology & Hepatology on biosimilars.

Help your patients understand all their IBD treatment options by sharing “What patients need to know about living with IBD” in the AGA GI Patient Center.

Share AGA patient education on your practice website or social media channels and tag @AmerGastroAssn.


Education for patients


Education for providers

Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.